Modification of adrenergic block by noradrenaline low temperature and sodium deficiency.
D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D001949:Bretylium Compounds / Q000494:pharmacology; D002794:Choline / Q000494:pharmacology; D003080:Cold Temperature; D003647:Debrisoquin / Q000494:pharmacology; D004147:Dioxins / Q000494:pharmacology; D004558:Electric Stimulation; D004987:Ethers / Q000494:pharmacology; D005029:Ethylenediamines / Q000494:pharmacology; D005260:Female; D006146:Guanidines / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007082:Ileum / Q000294:innervation*; D066298:In Vitro Techniques; D008297:Male; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology; D012964:Sodium / Q000502:physiology*; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013565:Sympatholytics / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014992:Xylenes / Q000494:pharmacology
D001593:Benzyl Compounds; D001949:Bretylium Compounds; D004147:Dioxins; D004987:Ethers; D005029:Ethylenediamines; D006146:Guanidines; D006634:Histamine H1 Antagonists; D011725:Pyridines; D013565:Sympatholytics; D014992:Xylenes; D012964:Sodium; D002794:Choline; D003647:Debrisoquin; D009638:Norepinephrine